SecBot SecBot
PRESS-RELEASE ·Filed Jul 17, 2026

COSM

Cosmos Health Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago WireGlobeNewswire
Press release · Buyback
Actionable Insight • Neutral

The buyback continues at a modest pace, reducing share count by ~6.5% of market cap. Monitor for further repurchases and any upcoming earnings release for fundamental context. The program's remaining capacity provides a floor but does not guarantee additional purchases.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
COSM ▲ +48.89% at T+60d
NEUTRAL call +48.89% · α vs SPY +44.21% · entry $0.2348 → $0.3496
Entry = T+0 close
Jul 17, 2026
via day close
T+1d
-1.92%
call -1.92% · α -1.76%
$0.2303
settled 3mo ago
T+5d
-14.91%
call -14.91% · α -14.22%
$0.1998
settled 3mo ago
T+20d
-7.20%
call -7.20% · α -11.64%
$0.2179
settled 2mo ago
T+60d
+48.89%
call +48.89% · α +44.21%
$0.3496
settled 15d ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health repurchased an additional 274,000 shares at ~$0.2554/share, bringing total buyback to 5,112,000 shares for ~$1.11M under its $5M program. The program continues through Dec 31, 2026, signaling management's view that shares are undervalued, but no financial results or material changes were disclosed.

Key Facts

  • Repurchased 274,000 shares at average price of ~$0.2554 per share
  • Total repurchased: 5,112,000 shares for approximately $1.11 million
  • Buyback program authorized up to $5 million, expires December 31, 2026
  • CEO stated shares remain undervalued relative to business strength

Financial Impact

Approximately $1.11 million in shares repurchased to date, with remaining capacity of ~$3.89 million under the $5M program

dilutionshare count

Risk Factors

  • Buyback may not be fully utilized if market conditions or cash flow deteriorate
  • No financial results or guidance provided to assess underlying business health

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3329254
33 reports for COSM
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 7 of 8 best @ T+60▲ +66.26%Jul 20, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2230 (−11.86%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2230 (−31.38%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2230 (−36.21%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2230 (+16.17%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2230 (−15.54%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2230 (−3.17%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2230 (−5.03%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2230 (−20.56%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2230 (−19.93%)
Jul 14, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2230 (−27.39%)
Showing 10 of 33

US Market Status

Market Open — Closes in 5h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 17, 2026